Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Connect Biopharma Holdings (CNTB) Equity Average (2024 - 2025)

Connect Biopharma Holdings' Equity Average history spans 2 years, with the latest figure at $63.4 million for Q3 2025.

  • For Q3 2025, Equity Average fell 40.11% year-over-year to $63.4 million; the TTM value through Sep 2025 reached $63.4 million, down 40.11%, while the annual FY2024 figure was $96.8 million, N/A changed from the prior year.
  • Equity Average for Q3 2025 was $63.4 million at Connect Biopharma Holdings, down from $77.1 million in the prior quarter.
  • Across five years, Equity Average topped out at $105.8 million in Q3 2024 and bottomed at $63.4 million in Q3 2025.